Secondary Central Nervous System Lymphoma: Risk Factors and Prophylaxis
- 3 August 2005
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 19 (4) , 751-763
- https://doi.org/10.1016/j.hoc.2005.05.008
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Incidence and risk factors for central nervous system occurrencein elderly patients with diffuse large-B-cell lymphoma: influenceof rituximabAnnals of Oncology, 2004
- Central nervous system involvement following diagnosis ofnon-Hodgkin’s lymphoma: a risk modelAnnals of Oncology, 2002
- CNS Involvement in Children With Newly Diagnosed Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2000
- Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patientsAnnals of Oncology, 2000
- CNS Involvement in Primary Mediastinal Large B-Cell LymphomaJournal of Clinical Oncology, 1999
- Isolated Central Nervous System Relapse in Aggressive Non-Hodgkin's Lymphoma: the Bologna ExperienceLeukemia & Lymphoma, 1999
- Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. ClassificationAnnals of Oncology, 1998
- For which patients with aggressive non-Hodgkin’s lymphoma is prophylaxis for central nervous system disease mandatory?Annals of Oncology, 1998
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- Central Nervous System Involvement in Patients with Diffuse Aggressive Non-Hodgkinʼs LymphomaAmerican Journal of Clinical Oncology, 1991